000 01408 a2200421 4500
005 20250518010842.0
264 0 _c20191002
008 201910s 0 0 eng d
022 _a1664-3224
024 7 _a10.3389/fimmu.2018.02404
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThorenoor, Nithyananda
245 0 0 _aSurvival of Surfactant Protein-A1 and SP-A2 Transgenic Mice After
_h[electronic resource]
260 _bFrontiers in immunology
_c2018
300 _a2404 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGenetic Variation
650 0 4 _aHost-Pathogen Interactions
_xgenetics
650 0 4 _aKlebsiella Infections
_xdrug therapy
650 0 4 _aKlebsiella pneumoniae
_xphysiology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aMice, Transgenic
650 0 4 _aPhagocytes
_ximmunology
650 0 4 _aPrognosis
650 0 4 _aPulmonary Surfactant-Associated Protein A
_xgenetics
650 0 4 _aSex Factors
700 1 _aUmstead, Todd M
700 1 _aZhang, Xuesheng
700 1 _aPhelps, David S
700 1 _aFloros, Joanna
773 0 _tFrontiers in immunology
_gvol. 9
_gp. 2404
856 4 0 _uhttps://doi.org/10.3389/fimmu.2018.02404
_zAvailable from publisher's website
999 _c29074414
_d29074414